Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the 'atherothrombogenic syndrome'. Oslo Diet and Exercise Study (ODES). A randomized trial

Journal of Internal Medicine

Volumn 240, Issue 4, 1996, Pages 203-209

  Anderssen, S A ^a   Hjermann, I ^b   Urdal, P ^b   Torjesen, P A ^c   Holme, I ^a,b  

^a NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cardiovascular risk factors; Diet; Exercise; Glucose; Insulin

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; BLOOD PRESSURE; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; EXERCISE; HUMAN; MAJOR CLINICAL STUDY; NORWAY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THROMBOGENICITY; TRAINING;

EID: 0029857241     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.22848000.x     Document Type: Article

References (27)

1. Dølvik JE, Danielsen Ø, Hernes G, FAFO and STUI, eds. Kluss i vekslinga. Fritid, idrett og organsering. Oslo: Nikolai Olsen, 1988.
2. Prevalence of sedentary lifestyle - behavioral risk factor surveillance system. United States, 1991. MMWR 1993; 42: 576-9.
3. Midthjell K, Bjørndal A, Holmen J, Krüger Ø, Bjartveit K. Prevalence of known and previously unknown diabetes mellitus and impaired glucose tolerance in an adult Norwegian population. Indications of an increasing diabetes prevalence. The Nord-Trøndelag diabetes study. Scand J Prim Health Care 1995; 13: 229-35.
4. Hjermann I. The Metabolic Cardiovascular Syndrome: Syndrome X, Reaven's Syndrome. Insulin Resistance Syndrome, Atherothrombogenic Syndrome. J Cardiovasc Pharmacol 1992; 20 (Suppl. 8): 5-10.
5. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
6. Hjermann I, Leren P, Norman N, Helgeland A, Holme I. Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men : the Oslo Study. Scand J Clin Lab Invest 1980; 40: 89-94.
7. Nilsson PM, Lindholm LH, Scherstén F. Life style changes improve insulin resistance in hyperinsulinaemic subjects: a one-year intervention study of hypertensives and normotensives in Dalby. J Hypertens 1992; 10: 1071-8.
8. Hellènius ML, Brismar K, Berglund B, de Faire U. Effects on glucose tolerance, insulin secretion, insulin-like growth factor-I and its binding protein IGFBP-1 in a randomized controlled diet and exercise study in healthy middle-aged men. J Intern Med 1995; 238: 121-30.
9. The ODES Investigators. The Oslo Diet and Exercise Study (ODES): design and objectives. Controlled Clin Trials 1993; 14: 229-43.
10. Balke B. Optimale Körperliche Leistungsfähigkeit, ihre Mess-ung und Veränderung infolge Arbeitserrrüdung. Arbeitsphysiologie 1954; 15: 311-23.
11. Solvoll K, Lund-Larsen K, Søyland E, Sandstad B, Drevon CA. A quantitative food frequency questionnaire evaluated in a group of dermatologie outpatients. Scand J Nutr 1993; 37: 50-5.
12. Bonaa KH, Bjerve KS, Straume B, Gram IT, Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension: A population-based intervention trial from the Tromso study. N Engl J Med 1990; 332: 795-801.
13. Vessby B, Boberg M. Dietary supplementation with n-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus. J Intern Med 1990; 228: 165-71.
14. Harris WS. Dietary fish oil and blood lipids. Curr Opin Lipidol 1996; 7: 3-7.
15. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. Diabetes Care 1992; 15: 318-67.
16. DeFronzo RA, Ferrannini E. Insulin resistance, a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
17. Alessi MC, Juan-Vague I, Kooistra T, DeClerk PJ, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor 1. Thromb Haemost 1988; 60: 491-4.
18. Pool PE. The case for metabolic hypertension: Is it time to restructure the hypertension paradigm? Prog Cardiovasc Dis 1993; XXXXVI: 1-38.
19. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
20. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged difference in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 355: 765-74.
21. Hodis HN, Mack WJ. Triglyceride-rich lipoproteins and the progression of coronary artery disease. Curr Opin Lipidol 1995; 6: 209-14.
22. Bass KM, Newsschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1993; 153: 2209-16.
23. Anderssen SA, Haaland A, Hjermann I, Urdal P, Gjesdal K, Holme I. Olso Diet and Exercise Study: A one year randomized intervention trial; effect on haemostatic variables and other coronary risk factors. Nutr, Metab Cardiovasc Dis 1995; 5: 189-200.
24. Anderssen SA, Holme I, Urdal P, Hjermann I. Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: The Oslo Diet and Exercise Study (ODES). Blood Press 1995; 4: 343-9.
25. Barnard RJ, Wen SJ. Exercise and diet in the prevention and control of the metabolic syndrome. Sports Med 1994; 18: 218-28.
26. O'Dea K. Diabetes in Australian Aborigines: impact of the western diet and life style. J Intern Med 1992; 232: 103-17.
27. O'Dea K, Patel M, Kubisch D, Hopper J, Traianedes K. Obesity, diabetes, and hyperlipidemia in a central Australian Ab-original community with a long history of acculturation. Diabetes Care 1993; 16: 1004-10.